2022年第15届欧洲临床药理学与治疗学协会大会(EACPT)

2022年第15届欧洲临床药理学与治疗学协会(EACPT)大会将于2022年6月26-28日在希腊雅典举行。

欧洲临床药理学与治疗学协会（EACPT）是临床药理学领域的学术团体，是欧洲领先的服务于欧洲和全球临床药理学和治疗学界的协会。EACPT成员包括所有欧洲的临床药理学国家组织，并为整个欧洲地区的4000多名对临床药理学和治疗学感兴趣宣的个人专业人士提供教育和科学支持。

EACTP 2022
15th Congress of the European Association for Clinical Pharmacology and Therapeutics
26-28 June 2022 | Athens, Greece

Dear Colleagues,

As the chair of EACPT I would like to cordially invite you to take part of the 15th Congress of the European Association for Clinical Pharmacology and Therapeutics in Athens, Greece, 26-28 June 2022.

The first congress of EACPT was held in Paris in 1995. This first congress has been followed by a very successful series of meetings all over Europe, bringing together scientists from all over the world in fruitful and enjoyable encounters. For the last congress in Stockholm in 2019, we had more than 500 delegates from 50 different countries. With the upcoming congress in Athens, Greece, we aim to surpass these numbers. The theme of the Congress will be “Clinical pharmacology meeting tomorrow´s health care challenges” addressing all current issues in modern therapeutics, from new diseases to personalized treatment approaches. We will be directing a lot of attention to COVID-19 pharmacologic issues such as the rapid trial designs employed during the pandemic and new investigational therapies and vaccines. This will be reflected in the program of our Congress which will consist of an exciting mixture of key notes, workshops, debates and scientific presentations.

Clinical pharmacologists embrace large domains and use many tools, from a molecular perspective on drug-target interactions, all the way through to individual patient care, patient group needs, and epidemiological and global considerations for the safe and effective use of medicines. In this meeting, we will all come together, share knowledge and discuss how we can use these tools to solve the many challenges of modern health care, e.g. population ageing worldwide, increasing prevalence of chronic diseases, new possibilities to treat the critically ill, health care sustainability, antimicrobial resistance and new viral threats to mankind.

Athens is a worldwide destination with attractive sites, formidable weather and a pleasant lifestyle that will certainly function as a magnet to attract many scientists. My sincere hope is that you will join us in this venture and contribute to make this an exciting and fruitful congress, for the sake of our patients, today and tomorrow!

Sincerely yours,

Professor Jamie Coleman

Chair of EACPT